Resultados de la búsqueda 1291-1300 of 11257 for anti-TNF drugs

  1. Oncología (médica) - Ensayos clínicos

    ... anti-tumor activity. Onvansertib For The Treatment Of Recurrent Or Refractory Chronic Myelomonocytic Leukemia. Rochester, Minn. This phase I trial evaluates ...

  2. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    All study subjects will receive acalabrutinib, durvalumab, and venetoclax. Acalabrutinib is FDA approved for treatment of chronic lymphocytic leukemia and small ...

  3. Oncología (médica) - Ensayos clínicos

    Anti-cancer activity will be assessed every 6 weeks during therapy and every 12 weeks thereafter. International Penile Advanced Cancer Trial (International Rare ...

  4. Oncología (médica) - Ensayos clínicos

    Drugs used in chemotherapy regimens such as UH-3 ... Anti-cancer activity will be assessed every 6 ... A Study of Standard Systemic Therapy with or without ...

  5. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    Anti-cancer activity will be assessed every 6 weeks during therapy and every 12 weeks thereafter. Prospective Use Of Philips ISuite For Interventional ...

  6. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    ABBV-383 is an investigational drug being developed for the treatment of R/R Multiple Myeloma (MM). ... The names of the study drugs involved in this study are: * ...

  7. Oncología (médica) - Ensayos clínicos

    Giving rituximab together with romidepsin and lenalidomide may be a better treatment for B-cell non-Hodgkin lymphoma. A Study of Women undergoing Mammogram ...

  8. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    Ascorbic acid may make cancer cells more sensitive to chemotherapy. Drugs used in chemotherapy, work in different ways to stop the growth of cancer cells, ...

  9. Hematología - Ensayos clínicos

    Giving rituximab together with romidepsin and lenalidomide may be a better treatment for B-cell non-Hodgkin lymphoma. Fertility Outcomes in Lymphoma Patients.

  10. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    The purpose of this trial is to evaluate the safety, tolerability, immunogenicity, pharmacokinetics (PK), pharmacodynamics (PD), and anti ... Drugs used in ...